Nooms Microdose program is specifically designed for women and men looking for a personalized, low-dose approach to weight management
A 2026 informational evaluation of MEDVi's GLP-1 weight loss program structure, compounded semaglutide and branded Ozempic access pathways, published pricing disclosures, three-entity telehealth model, refund terms, and the regulatory and disclosure context relevant to online GLP-1 treatment programs Newark, DE, March 17, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only
17 Study participants received a standard oral (50 gram) sucrose load and randomized to placebo or escalating doses of D-allulose (2.5, 5.0, 7.5, 10.0 grams)
We honor her vision by continuing to formulate with Raw Shea Butter handcrafted by women in Africa